Top vaccine makers Merck and Pfizer target China and older adults next
May 12, 2019 at 11:00 AM EDT
Four giant companies now dominate global vaccine sales. With newer and more expensive vaccines becoming available, the market value of vaccines could rise to $100 billion by 2025.